Targeting CD123 in BPDCN: an emerging field-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting CD123 in BPDCN: an emerging field

Published:2021-10-29 Issue:11 Volume:14 Page:993-1004
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

DiPippo Adam J¹^ORCID,Wilson Nathaniel R²,Pemmaraju Naveen³

Affiliation:

1. Clinical Pharmacy Specialist, Pharmacy Clinical Programs, The University of Texas Md Anderson Cancer Center, Houston,Texas US

2. Resident Physician, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, US

3. Associate Professor, Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, US

Funder

The University of Texas MD Anderson Cancer Center

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2021.1988848

Reference114 articles.

1. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

2. Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights

3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

4. Blastic Plasmacytoid Dendritic Cell Neoplasm

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment;Frontiers in Medicine;2024-07-17

2. Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells;Cancer Immunology Research;2024-05-30

3. Azacitidine maintenance therapy for blastic plasmacytoid dendritic cell neoplasm allograft: A case report;World Journal of Clinical Cases;2024-01-06

4. Sniping Cancer Stem Cells with Nanomaterials;ACS Nano;2023-11-27

5. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer;Molecular Cancer;2023-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3